FDA recall D-0075-2018

Genzyme Corporation · Class III · drug

Product

Clolar (clofarabine) 20 mg/20 mL (1 mg/mL) Injection, for intravenous use, Rx Only, Mfd. by: Teva Pharmachemie Swensweg 5 Haarlem, The Netherlands Mfd. for: Genzyme Corporation, Cambridge, MA 02142, NDC 0024-5860-01.

Reason for recall

Labeling: Incorrect or Missing Package Insert.

Distribution

Nationwide

Key facts

Status
Terminated
Initiation date
2017-10-12
Report date
2017-11-22
Termination date
2020-09-10
Voluntary/Mandated
Voluntary: Firm initiated
Location
Northborough, MA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0075-2018